Improving cancer immunotherapy by targeting IL-1

被引：6
|
作者：
Xiao, Zhilan [1 ]
Singh, Shubhra [2 ]
Singh, Manisha [2 ]
机构：
[1] Indiana Univ Sch Med, Dept Internal Med, Indianapolis, IN 46202 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA
来源：
ONCOIMMUNOLOGY | 2021年 / 10卷 / 01期
关键词：
Inflammation; IL-1; cancer; immunotherapy; INTERLEUKIN-1; ACIDOSIS; CELLS;
D O I：
10.1080/2162402X.2021.2008111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Interleukin-1 (IL-1) is an inflammatory cytokine associated with tumor invasiveness and metastasis. We recently found that baseline IL-1 in melanomas promoted resistance to immunotherapy by creating an immunosuppressive tumor microenvironment and that IL-1 produced in response to CD40 agonist also induced resistance to therapy. Here, we discuss how naturally occurring and immunotherapy-induced IL-1 in tumors causes immune suppression and resistance to immunotherapy, and we discuss targeting the IL-1 pathway to enhance the efficacy of immunotherapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Improving the Potency of Cancer Immunotherapy by Dual Targeting of IDO1 and DNA
    Fang, Kun
    Dong, Guoqiang
    Wang, Hongyu
    He, Shipeng
    Wu, Shanchao
    Wang, Wei
    Sheng, Chunquan
    CHEMMEDCHEM, 2018, 13 (01) : 30 - 36
  • [22] Targeting the IL-9 pathway in cancer immunotherapy
    Zheng, Ningbo
    Lu, Yong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2333 - 2340
  • [23] Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
    Luo, Zhangyi
    Eichinger, Katherine M.
    Zhang, Anju
    Li, Song
    CANCER LETTERS, 2023, 575
  • [24] Improving efficacy of cancer immunotherapy through targeting of macrophages
    Peranzoni, Elisa
    Donnadieu, Emmanuel
    M S-MEDECINE SCIENCES, 2019, 35 (03): : 207 - 209
  • [25] Improving efficacy of cancer immunotherapy through targeting of macrophages
    Peranzoni, Elisa
    Donnadieu, Emmanuel
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) : 189 - 192
  • [26] Therapeutic potential of targeting IL-1 and IL-18 in inflammation
    Braddock, M
    Quinn, A
    Canvin, J
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (06) : 847 - 860
  • [27] Targeting of Notch, IL-1, and leptin has therapeutic potential in xenograft colorectal cancer
    Ozyurt, Rumeysa
    Erkasap, Nilufer
    Ozkurt, Mete
    Erkasap, Serdar Mustafa
    Dimas, Konstantinos
    Gundogdu, Ayse Cakir
    Ulukaya, Engin
    TURKISH JOURNAL OF BIOLOGY, 2023, 47 (04) : 290 - 300
  • [28] Targeting IL-1β as a Preventive Modality for K-ras Mutant Lung Cancer
    Yuan, B.
    Clowers, M. J.
    Velasco, W. V.
    Ramos-Castaneda, M.
    Peng, S.
    Moghaddam, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [29] Targeting the IL-1 family members in skin inflammation
    Jensen, Liselotte E.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (11) : 1211 - 1220
  • [30] Helminth products prevent autoimmunity by targeting IL-1
    Quinn, Shauna
    Mills, Kingston H. G.
    CYTOKINE, 2017, 100 : 167 - 167
12345